Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
133.7 USD | +1.26% | +1.46% | +1.44% |
Apr. 17 | Nxera Pharma's Neuro Drug NBI-1117568 Passed Preclinical Toxicity Test | MT |
Apr. 16 | Neurocrine Biosciences, Sentia Medical Sciences Extend Partnership on Prospective Drug Development | MT |
- Stock Market
- Equities
- NBIX Stock
- News Neurocrine Biosciences, Inc.